Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Free fatty acids merit targeted investigation in obesity-linked cardiometabolic disease; leaves open specific diagnostics and therapies.
Increased plasma FFA levels are an important cause of obesity-associated insulin resistance and cardiovascular disease. Therapeutic application of this knowledge is hampered by the lack of readily accessible methods to measure FFA and by the lack of medications to lower plasma FFA levels.
No takes yet. Share an insight, caveat, or question.
Guenther Boden (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: